AdV-HSV1-TK
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AdV-HSV1-TK, covering 2026-03-11 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors [Phase 1]